NHS Grants Palantir Unlimited Access to Patient Data
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 11 hours ago
0mins
Should l Buy PLTR?
Source: Newsfilter
- Access Permission Change: The UK's National Health Service (NHS) has decided to grant staff from companies including Palantir 'unlimited access' to identifiable patient data to support the development of its flagship data platform, raising significant public concern over data privacy.
- Large Contract Value: Palantir secured a £330 million ($448.4 million) contract in 2023 to develop the National Data Integration Tenant (NDIT) for the NHS, aimed at integrating disparate NHS datasets into a single system to enhance data management efficiency.
- External Access Management: NHS has agreed to create an 'admin' role allowing non-staff unlimited access to the NDIT and identifiable patient data, although an internal briefing note recommends capping external admin access and subjecting such permissions to regular review to ensure data security.
- Public Scrutiny and Review: Palantir's data access has drawn considerable public scrutiny due to its work with U.S. government defense agencies, with the briefing note suggesting that external access should be time-limited and regularly reviewed to address concerns over patient data access.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PLTR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PLTR
Wall Street analysts forecast PLTR stock price to rise
17 Analyst Rating
5 Buy
10 Hold
2 Sell
Hold
Current: 137.800
Low
50.00
Averages
192.88
High
255.00
Current: 137.800
Low
50.00
Averages
192.88
High
255.00
About PLTR
Palantir Technologies Inc. is engaged in building software to assist in counterterrorism investigations and operations. The Company has built four principal software platforms, including Palantir Gotham (Gotham), Palantir Foundry (Foundry), Palantir Apollo (Apollo), and Palantir Artificial Intelligence Platform (AIP). Apollo is a cloud-agnostic, single control layer that coordinates ongoing delivery of new features, security updates, and platform configurations, helping to ensure the continuous operation of critical systems. Gotham enables users to identify patterns hidden deep within datasets, ranging from signals intelligence sources to reports from confidential informants. Foundry transforms the ways organizations operate by creating a central operating system for their data. AIP enables responsible artificial intelligence (AI)-advantage across the enterprise by using primary, core components built to effectively activate large language models and other AI within any organization.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Palantir Q1 Results Exceed Expectations, Strong Growth Momentum
- Significant Revenue Growth: Palantir's Q1 revenue surged 85% year-over-year to $1.63 billion, surpassing Wall Street expectations, indicating strong demand and sustainable growth potential in the AI software market.
- Customer Base Expansion: The number of Palantir's customers increased by 31% year-over-year to 1,007, demonstrating the company's success in attracting new clients and expanding contracts with existing ones, further driving future revenue growth.
- Contract Value Increase: The total contract value signed in Q1 reached $2.4 billion, a 61% increase from the previous year, reflecting higher spending from existing customers and the addition of new clients, laying a solid foundation for future performance.
- Improved Profitability: Palantir reported adjusted earnings of $0.33 per share, more than doubling from $0.13 a year ago, showcasing the company's effective strategies in enhancing customer spending and profit margins.
See More
Analyst Opinions Impact Palantir Stock Price
- Stock Performance: Palantir Technologies has seen a decline of approximately 24.4% year-to-date, indicating market concerns regarding its future growth potential, which may negatively impact investor confidence and capital inflows.
- Analyst Ranking: The ranking is derived from averaging analyst opinions for each component, resulting in a comprehensive evaluation of 500 components, which suggests a generally negative sentiment towards Palantir.
- Market Reaction: Analyst views and ratings can directly influence Palantir's stock price volatility, particularly in the current economic climate where investors are highly sensitive to tech stocks.
- Industry Impact: As market interest in Palantir wanes, it may lose market share in the competitive tech industry, further exacerbating downward pressure on its stock price.
See More
Palantir Reports 85% Revenue Growth in Q1, Sets New Record
- Significant Revenue Growth: Palantir's Q1 2026 revenue surged 85% year-over-year to $1.63 billion, exceeding Wall Street expectations, indicating strong demand for its AI software platform and suggesting potential for continued growth.
- Accelerated Customer Expansion: The company's customer count rose 31% year-over-year to 1,007, with total contracts signed reaching $2.4 billion, a 61% increase, reflecting Palantir's ability to capture larger market shares among both existing and new clients.
- Enhanced Profitability: Adjusted earnings per share soared to $0.33, more than 2.5 times the previous year's $0.13, demonstrating significant margin improvement driven by higher spending from existing customers.
- Optimistic Market Outlook: Palantir anticipates revenue of $7.66 billion in 2026, up from $7.19 billion, representing a 71% increase, and further guidance hikes are likely as the AI software market continues to expand rapidly.
See More
Comparison of Stock Performance: PLTR vs SATS
- Stock Performance Analysis: PLTR is currently trading down approximately 2.5%, reflecting a cautious market sentiment regarding its future performance, which may impact investor confidence and lead to capital outflows.
- SATS Recovery: In contrast, SATS is up about 1%, indicating a more optimistic market outlook on its business prospects, potentially attracting more investor interest.
- Market Sentiment Comparison: The contrasting stock movements of PLTR and SATS highlight differing market perceptions, with PLTR's decline possibly linked to recent performance issues or changes in market conditions, while SATS benefits from positive market feedback.
- Investor Strategy Adjustment: Investors may need to reassess their investment strategies regarding PLTR, considering the reasons behind its stock decline and potential future risks, while also keeping an eye on growth opportunities with SATS.
See More
Palantir Faces Growing Debate Over Healthcare Data Privacy
- Data Access Controversy: A Financial Times report claims that NHS England granted contractors, including Palantir, broad access to identifiable patient information, raising significant concerns about healthcare data privacy, particularly given the sensitivity of NHS medical records.
- Internal Review Raises Eyebrows: An internal NHS briefing indicated that some external staff working on the National Data Integration Tenant system had what was described as 'unlimited access' to patient data, immediately prompting public scrutiny, especially as Palantir's government and healthcare work has been closely monitored in recent years.
- NHS Response: Although NHS attempted to alleviate concerns by emphasizing existing strict safeguards and regular audits, external workers still require government security clearance and approval from senior NHS leadership to access the system, highlighting the importance placed on data privacy.
- Business Implications: Palantir's business increasingly relies on government and healthcare contracts tied to AI, analytics, and massive data management systems, but these deals also attract intense public scrutiny regarding privacy and oversight, potentially impacting future contract acquisitions and the company's reputation.
See More
Nvidia Earnings Preview: Rising AI Bubble Risks
- Palantir Beats Expectations: Palantir's Q1 revenue surged 85% to $1.63 billion, driven by 84% growth in U.S. government revenue and a doubling of U.S. commercial sales, with CEO Karp raising 2026 sales growth guidance from 61% to 71%, highlighting its strong position in AI applications.
- Stock Price Decline: Despite exceeding Wall Street expectations, Palantir's shares fell over 8% in the two days following its report, primarily due to investor concerns over its valuation, particularly with a price-to-sales ratio still above 60, significantly higher than historical industry norms.
- Nvidia's Earnings Outlook: Nvidia is expected to report jaw-dropping sales and profit growth on May 20, bolstered by its unmatched GPU computing capabilities and the ecosystem created by its CUDA software platform, but market expectations are exceedingly high.
- Increasing Internal Competition: Nvidia faces growing internal competition as key customers develop their own GPUs and AI solutions, which, while inferior in performance, are more cost-effective, potentially undermining Nvidia's pricing power and gross margins.
See More
Palantir Q1 Results Exceed Expectations, Strong Growth Momentum
- Significant Revenue Growth: Palantir's Q1 revenue surged 85% year-over-year to $1.63 billion, surpassing Wall Street expectations, indicating strong demand and sustainable growth potential in the AI software market.
- Customer Base Expansion: The number of Palantir's customers increased by 31% year-over-year to 1,007, demonstrating the company's success in attracting new clients and expanding contracts with existing ones, further driving future revenue growth.
- Contract Value Increase: The total contract value signed in Q1 reached $2.4 billion, a 61% increase from the previous year, reflecting higher spending from existing customers and the addition of new clients, laying a solid foundation for future performance.
- Improved Profitability: Palantir reported adjusted earnings of $0.33 per share, more than doubling from $0.13 a year ago, showcasing the company's effective strategies in enhancing customer spending and profit margins.
See More
Analyst Opinions Impact Palantir Stock Price
- Stock Performance: Palantir Technologies has seen a decline of approximately 24.4% year-to-date, indicating market concerns regarding its future growth potential, which may negatively impact investor confidence and capital inflows.
- Analyst Ranking: The ranking is derived from averaging analyst opinions for each component, resulting in a comprehensive evaluation of 500 components, which suggests a generally negative sentiment towards Palantir.
- Market Reaction: Analyst views and ratings can directly influence Palantir's stock price volatility, particularly in the current economic climate where investors are highly sensitive to tech stocks.
- Industry Impact: As market interest in Palantir wanes, it may lose market share in the competitive tech industry, further exacerbating downward pressure on its stock price.
See More
Palantir Reports 85% Revenue Growth in Q1, Sets New Record
- Significant Revenue Growth: Palantir's Q1 2026 revenue surged 85% year-over-year to $1.63 billion, exceeding Wall Street expectations, indicating strong demand for its AI software platform and suggesting potential for continued growth.
- Accelerated Customer Expansion: The company's customer count rose 31% year-over-year to 1,007, with total contracts signed reaching $2.4 billion, a 61% increase, reflecting Palantir's ability to capture larger market shares among both existing and new clients.
- Enhanced Profitability: Adjusted earnings per share soared to $0.33, more than 2.5 times the previous year's $0.13, demonstrating significant margin improvement driven by higher spending from existing customers.
- Optimistic Market Outlook: Palantir anticipates revenue of $7.66 billion in 2026, up from $7.19 billion, representing a 71% increase, and further guidance hikes are likely as the AI software market continues to expand rapidly.
See More
Comparison of Stock Performance: PLTR vs SATS
- Stock Performance Analysis: PLTR is currently trading down approximately 2.5%, reflecting a cautious market sentiment regarding its future performance, which may impact investor confidence and lead to capital outflows.
- SATS Recovery: In contrast, SATS is up about 1%, indicating a more optimistic market outlook on its business prospects, potentially attracting more investor interest.
- Market Sentiment Comparison: The contrasting stock movements of PLTR and SATS highlight differing market perceptions, with PLTR's decline possibly linked to recent performance issues or changes in market conditions, while SATS benefits from positive market feedback.
- Investor Strategy Adjustment: Investors may need to reassess their investment strategies regarding PLTR, considering the reasons behind its stock decline and potential future risks, while also keeping an eye on growth opportunities with SATS.
See More
Palantir Faces Growing Debate Over Healthcare Data Privacy
- Data Access Controversy: A Financial Times report claims that NHS England granted contractors, including Palantir, broad access to identifiable patient information, raising significant concerns about healthcare data privacy, particularly given the sensitivity of NHS medical records.
- Internal Review Raises Eyebrows: An internal NHS briefing indicated that some external staff working on the National Data Integration Tenant system had what was described as 'unlimited access' to patient data, immediately prompting public scrutiny, especially as Palantir's government and healthcare work has been closely monitored in recent years.
- NHS Response: Although NHS attempted to alleviate concerns by emphasizing existing strict safeguards and regular audits, external workers still require government security clearance and approval from senior NHS leadership to access the system, highlighting the importance placed on data privacy.
- Business Implications: Palantir's business increasingly relies on government and healthcare contracts tied to AI, analytics, and massive data management systems, but these deals also attract intense public scrutiny regarding privacy and oversight, potentially impacting future contract acquisitions and the company's reputation.
See More
Nvidia Earnings Preview: Rising AI Bubble Risks
- Palantir Beats Expectations: Palantir's Q1 revenue surged 85% to $1.63 billion, driven by 84% growth in U.S. government revenue and a doubling of U.S. commercial sales, with CEO Karp raising 2026 sales growth guidance from 61% to 71%, highlighting its strong position in AI applications.
- Stock Price Decline: Despite exceeding Wall Street expectations, Palantir's shares fell over 8% in the two days following its report, primarily due to investor concerns over its valuation, particularly with a price-to-sales ratio still above 60, significantly higher than historical industry norms.
- Nvidia's Earnings Outlook: Nvidia is expected to report jaw-dropping sales and profit growth on May 20, bolstered by its unmatched GPU computing capabilities and the ecosystem created by its CUDA software platform, but market expectations are exceedingly high.
- Increasing Internal Competition: Nvidia faces growing internal competition as key customers develop their own GPUs and AI solutions, which, while inferior in performance, are more cost-effective, potentially undermining Nvidia's pricing power and gross margins.
See More
